2146 Results

People

  1. Aghajanian
    Aghajanian
  2. Hensley
    Hensley
  3. Abu-Rustum
    Abu-Rustum
  4. O'Cearbhaill
    O'Cearbhaill
  5. Makker
    Makker
  6. Tew
    Tew
  7. Lichtman
    Lichtman
  8. Zamarin
    Zamarin
  9. Chi
    Chi
  10. Iasonos
    Iasonos

Groups

  1. Gynecologic Medicine Service (2146)
  2. Solid Tumor Oncology Division (2146)
  3. Department of Medicine (2142)
  4. Gynecology Disease Management Team (1846)
  5. GDMT, Medicine (1828)
  6. Surgery (594)
  7. GDMT, Surgery (474)
  8. Epidemiology and Biostatistics (398)
  9. Department of Pathology and Laboratory Medicine (395)
  10. Survivorship Research (390)
  1. "Gynecologic Medicine Service"
Formats
  1. Journal Article (1087)
  2. Meeting Abstract (890)
  3. Review (52)
  4. Book Section (46)
  5. Editorial (35)
  6. Guidelines (21)
  7. Correspondence (9)
  8. Miscellaneous (3)
  9. Research Letter (2)
  10. Book Whole (1)
Groups
  1. Gynecologic Medicine Service (2146)
  2. Solid Tumor Oncology Division (2146)
  3. Department of Medicine (2142)
  4. Gynecology Disease Management Team (1846)
  5. GDMT, Medicine (1828)
  6. Surgery (594)

More Groups

People
  1. Carol Aghajanian (607)
  2. Martee Hensley (289)
  3. Nadeem Abu-Rustum (288)
  4. Roisin O'Cearbhaill (271)
  5. Vicky Makker (263)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (41)
  2. 2024 (167)
  3. 2023 (171)
  4. 2022 (209)
  5. 2021 (163)
  6. 2020 (203)

More Years

Publications
  1. Journal of Clinical Oncology (450)
  2. Gynecologic Oncology (418)
  3. International Journal of Gynecological Cancer (154)
  4. Annals of Oncology (116)
  5. Clinical Cancer Research (67)
  6. Cancer Research (55)

More Publications

Publishers
  1. Elsevier Inc. (542)
  2. American Society of Clinical Oncology (489)
  3. Lippincott Williams & Wilkins (181)
  4. American Association for Cancer Research (168)
  5. Oxford University Press (143)
  6. Nature Publishing Group (86)

More Publishers

Results (2146)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade
    Journal Article

    Gomez-Roca, C.; Cassier, P.; Zamarin, D.; Machiels, J. P.; Perez Gracia, J. L.; Hodi, F. S.; Taus, A.; Martinez Garcia, M.; Boni, V.; Eder, J. P.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • CD74-NRG1 fusions are oncogenic in vivo and induce therapeutically tractable ERBB2:ERBB3 heterodimerization
    Journal Article

    Werr, L.; Plenker, D.; Dammert, M. A.; Lorenz, C.; Brägelmann, J.; Tumbrink, H. L.; Klein, S.; Schmitt, A.; Büttner, R.; Persigehl, T.; more...
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • Histologic features of uterine leiomyosarcomas clinically profiled by targeted DNA-based next generation sequencing
    Meeting Abstract

    Riviere, S.; Boroujeni, A. M.; Hensley, M.; Ladanyi, M.; Ellenson, L.; Chiang, S.
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Histologic features of uterine leiomyosarcomas clinically profiled by targeted DNA-based next generation sequencing
    Meeting Abstract

    Riviere, S.; Boroujeni, A. M.; Hensley, M.; Ladanyi, M.; Ellenson, L.; Chiang, S.
    Laboratory Investigation (2022)

    Fulltext@MSK | Save
  • DS-7300 (B7-H3 DXd-ADC) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): A subgroup analysis of a phase 1/2 multicenter study
    Meeting Abstract

    Patel, M. R.; Johnson, M. L.; Falchook, G. S.; Doi, T.; Friedman, C. F.; Piha-Paul, S. A.; Gutierrez, M.; Shimizu, T.; Cheng, B.; Qian, M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Semisupervised training of a brain MRI tumor detection model using mined annotations
    Journal Article

    Swinburne, N. C.; Yadav, V.; Kim, J.; Choi, Y. R.; Gutman, D. C.; Yang, J. T.; Moss, N.; Stone, J.; Tisnado, J.; Hatzoglou, V.; more...
    Radiology (2022)

    Fulltext@MSK | Save
  • AKT mutant allele-specific activation dictates pharmacologic sensitivities
    Journal Article

    Shrestha Bhattarai, T.; Shamu, T.; Gorelick, A. N.; Chang, M. T.; Chakravarty, D.; Gavrila, E. I.; Donoghue, M. T. A.; Gao, J.; Patel, S.; Gao, S. P.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma
    Journal Article

    Stover, E. H.; Xiong, N.; Myers, A. P.; Tayob, N.; Engvold, V.; Polak, M.; Broaddus, R. R.; Makker, V.; Drapkin, R.; Liu, J. F.; more...
    Gynecologic Oncology Reports (2022)

    Fulltext@MSK | Save
  • Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas
    Journal Article

    Crowley, F.; Cadoo, K. A.; Chiang, S.; Mandelker, D. L.; Bajwa, R.; Iasonos, A.; Zhou, Q. C.; Miller, K. M.; Hensley, M. L.; O'Cearbhaill, R. E.
    Gynecologic Oncology Reports (2022)

    Fulltext@MSK | Save
  • Lenvatinib dose, efficacy, and safety in the treatment of multiple malignancies
    Review

    Motzer, R. J.; Taylor, M. H.; Evans, T. R. J.; Okusaka, T.; Glen, H.; Lubiniecki, G. M.; Dutcus, C.; Smith, A. D.; Okpara, C. E.; Hussein, Z.; more...
    Expert Review of Anticancer Therapy (2022)

    Fulltext@MSK | Save